In 2023, CR Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, CR Medical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of CR Medical amounted to 177,112.78 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of CR Medical increased by 134.11%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of CR Medical were 1,359.06 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2020, CR Medical's Scope 1 emissions have decreased by 75.91%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), CR Medical's Scope 1 emissions decreased by 81.9%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2023, CR Medical reported Scope 2 greenhouse gas (GHG) emissions of 175,753.72 tCOâ‚‚e without specifying the calculation method.
Since 2020, CR Medical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 111.6%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), CR Medical's Scope 2 emissions (Unspecified Calculation Method) rose by 157.91% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2023, CR Medical reported its Scope 2 emissions using an unspecified methodology.